Bioelectronics Corp (BIEL)

[uksausage]

it is interesting to note that the R&D expenditure has been consistent.
If there were only "the product" as you put it (actually three - loop, heel and allay) they wouldn't need to do more R&D.
IMHO a number of new products coming but not going to "launch" as that takes cash.
higher powered RecoveryRx for BBraun is one item, deeper penetrating one for internal surgery recovery another. BPH one may need special mechanism for looping/attaching.

So BIEL is not a one trick pony when considering value to a pharma buyout.

I am certain there will be bids once FDA clearance is given but will Andy sell?

I suspect an offer over 5c will be attractive.